… Program for FY 2018 a. Adoption of Modified PSI 90: Patient Safety and Adverse Events Composite (NQF #0531) (1) Background (2) Overview of the Measure Changes (3) Risk Adjustment (4) Adoption of the NQF-Endorsed Version of the Modified PSI 90 b. Applicable Time Periods for the F…

…mans Cells Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2016 08; 36(8):1692-7. Januzzi JL, Lyass A, Liu Y, Gaggin H, Trebnick A, Maisel AS , D'Agostino RB, Wang TJ , Massar…